Home LiteratureArticle Details
PMID: 416488 Published · ppublish English Journal Article

Carriage of Neisseria meningitidis in a semi-isolated arctic community.

Scandinavian journal of infectious diseases ·Vol. 10 ·No. 1 ·1978-00-00 ·Pages 36-40

Holten E, Bratlid D, Bøvre K

Abstract

The carriage of Neisseria meningitidis was examined in the Norwegian population of Svalbard (1150 persons) after a fatal case of meningococcal septicaemia. The overall carrier rate was 39.0%. The rate was highest among males (47.8%), with a maximum of 63.4% in the age group 15-24 years. The carrier rate was low among children aged 3 to 15 years (6.5%). Children below 3 years were frequent meningococcal carriers, however (37.5%). Sulphonamide-resistant strains were often found, 22.6% of the total material being resistant. Group B was the most frequent serogroup, and accounted for 44.5% of the isolated strains. Non-groupable strains were second in frequency (23.8%), followed by group Y (15.8%). Only a few strains belonged to the serogroups A, C, X and Z. N. lactamica was isolated from 26.9% of children below 15 years, but seldom in older age groups.

MeSH Terms
Adolescent Adult Age Factors Carrier State/epidemiology Child Child, Preschool Drug Resistance, Microbial Female Humans Male Meningococcal Infections/epidemiology Neisseria meningitidis/drug effects,isolation & purification Sex Factors Sulfonamides/pharmacology Svalbard
Chemicals
Sulfonamides
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Holten E
Bratlid D
Bøvre K
Article Info
Journal
Scandinavian journal of infectious diseases
Abbr.
Scand J Infect Dis
ISSN
0036-5548
Published
1978-00-00
Pages
36-40
Language
English
Region
England
NLM ID
0215333
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com